Search - tctmd.com

Displaying 941 - 960 of 1143

Sort: Relevancy | Date

Presentation TCT 2015

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, DJ Lakkireddy

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Presentation TCT 2015

Surgical LAA Closure: Patient Selection and Supporting Data

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Michael Argenziano

October 11, 2015

Presentation TCT 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Uwe Zeymer

October 11, 2015

Presentation TCT 2015

What Are the Management Options for the Patient With AF and DES?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Pascal Vranckx

October 11, 2015

Presentation TCT 2015

Which NOAC for Which Patient?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Christopher B. Granger

October 11, 2015

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Presentation CICT 2015

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Presenter: Horst Sievert

August 01, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation TVT 2015

Thoughtful Commentary: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Fabian Nietlispach

June 04, 2015

Presentation TVT 2015

Case Presentation: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Brij Maini

June 04, 2015

Presentation Fellows 2015

Good Transseptal Technique and the Procedures You Can Do With It (LAA, Mitral, and Beyond)

Presenter: Mark Reisman, Nirat Beohar

May 17, 2015

Presentation

Safety of LAA Exclusion With the Lariat Device

Presenter: S. Chatterjee

May 04, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Presenter: Ram?n L?pez M?nguez

January 14, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Advertisement

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Surgical LAA Closure: Patient Selection and Supporting Data

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

What Are the Management Options for the Patient With AF and DES?

Which NOAC for Which Patient?

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Thoughtful Commentary: LAA Occlusion and TAVR

Case Presentation: LAA Occlusion and TAVR

Good Transseptal Technique and the Procedures You Can Do With It (LAA, Mitral, and Beyond)

Safety of LAA Exclusion With the Lariat Device

LAA Occlusion for Stroke Prevention in A-Fib

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content